The inflammation interfering with your metabolism, hormones, and energy isn’t the kind you can feel. Here’s what it looks like, how it’s measured, and what to do about it.
When most people hear the word inflammation, they picture something obvious. A swollen joint. A sprained ankle. Redness after an injury. Something that arrived with a clear cause and will resolve with time.
That kind of inflammation, acute, visible, purposeful, is your immune system doing exactly what it’s designed to do.
The inflammation that interferes most with metabolic and hormonal health looks nothing like that. It’s chronic, low-grade, and silent.
In chronic low-grade inflammation, inflammatory signaling molecules called cytokines, particularly interleukin-6, TNF-alpha, and interleukin-1 beta, remain elevated in the background.[1] It’s maintained by a constellation of inputs: excess visceral fat, chronic stress, poor sleep, dysbiosis in the gut microbiome, nutrient deficiencies, and metabolic dysfunction.
This is not inflammation you can feel. You won’t wake up one morning and recognize it as the source of your fatigue or your stalled weight loss. That’s precisely what makes it so clinically significant: it persists undetected while quietly undermining the systems that depend on a stable internal environment to function.
Chronic low-grade inflammation rarely presents as a single obvious symptom. It shows up as a pattern, one that often goes unrecognized because no individual piece of it looks alarming enough to investigate further.
Inflammatory cytokines interfere with leptin signaling, the hormone that tells your brain you’ve had enough food and that it’s safe to release stored fat for energy. When leptin resistance develops in an inflammatory environment, the brain operates as though the body is in a state of deprivation even when it isn’t. Fat loss becomes metabolically harder, not just behaviorally harder.
This is a pattern I see often in practice. A patient starts hormone therapy, the labs look appropriate, the dose seems right, and yet the expected improvements in energy, mood, sleep, and body composition don’t materialize. Chronic inflammation can be the missing variable: inflammatory signaling may reduce how well cells respond to hormones, so the hormones are present but not working as efficiently. It’s one reason hormone balancing isn’t always working even when the numbers look right.
Persistent fatigue without obvious illness or sleep deprivation is one of the most common presentations. Inflammatory signaling alters mitochondrial function and activates what researchers call “sickness behavior,” a conserved biological response that promotes rest and withdrawal.[5] When this system is chronically activated at a low level, the result is fatigue that is real, physiological, and not resolved by more sleep or more caffeine.
Diffuse achiness, morning stiffness, or joints that feel inflamed without a specific injury or autoimmune diagnosis can be early signs of systemic inflammatory load. In the context of metabolic dysfunction, this pattern is common and frequently overlooked.
Two of the most clinically useful markers for identifying chronic low-grade inflammation are high-sensitivity C-reactive protein and fasting insulin. Neither is included on most standard annual panels.
hs-CRP is produced by the liver in response to inflammatory signaling. Elevated hs-CRP, even at levels below the threshold typically flagged as abnormal, is associated with increased cardiovascular risk, metabolic dysfunction, and blunted response to hormonal and nutritional interventions.[2]
Optimal levels from a functional medicine standpoint are below 1.0 mg/L. Many patients walking around with “normal” CRP results are sitting at 2.0, 3.0, or higher: not high enough to trigger a flag, but high enough to matter.
Fasting insulin is not an inflammatory marker directly, but it is one of the most sensitive indicators of the metabolic environment in which inflammation thrives. Insulin resistance and chronic inflammation exist in a bidirectional relationship: each promotes and sustains the other.[3][4]
Elevated fasting insulin signals that the metabolic conditions driving inflammation are active, even when glucose and A1c remain normal. It is also one of the earliest markers to move, often rising years before glucose or other conventional markers change.
Together, these two markers give a picture of inflammatory and metabolic status that fasting glucose, a basic metabolic panel, and a standard lipid panel simply cannot provide.
One of the most important principles in functional medicine is that interventions are only as effective as the environment they’re applied to. This is where chronic low-grade inflammation becomes a strategic problem, not just a health problem.
Patients invest in hormone therapy, targeted supplementation, weight loss protocols, and nutritional changes. These are often the right tools. But if the underlying inflammatory environment isn’t identified and addressed, the tools don’t work the way they should. The body is operating in a state of physiological resistance that no single protocol can overcome in isolation.
This is not a reason to delay intervention. It’s a reason to test comprehensively before and during intervention, so that what’s underneath the surface is visible, and the strategy can address the full picture rather than just the most obvious layer.
Chronic inflammation is driven by the same inputs that drive metabolic dysfunction broadly:
These are modifiable. But you can’t modify what you haven’t measured.
The Metabolic Makeover guide walks you through the key drivers of metabolic dysfunction, including the lab markers, lifestyle levers, and nutritional strategies that address the root causes, not just the symptoms.
Free instant download. No spam, unsubscribe anytime.
A functional medicine evaluation for chronic low-grade inflammation goes beyond the standard panel. A thorough workup typically includes:
| Marker | What It Shows |
|---|---|
| hs-CRP and fasting insulin | Inflammatory load and the metabolic environment that feeds it |
| HOMA-IR | Insulin resistance, from fasting insulin and fasting glucose together |
| Advanced lipid panel | Particle size and number, more sensitive to metabolic inflammation than total cholesterol or standard LDL |
| Homocysteine | Impaired methylation; independently associated with cardiovascular and inflammatory risk |
| Comprehensive thyroid panel | TSH, free T3, free T4, and antibodies; hypothyroidism and Hashimoto’s drive both metabolic dysfunction and inflammation |
| Sex hormones and cortisol | Estrogen, progesterone, testosterone, DHEA-S, and cortisol; hormones and inflammation influence each other |
| Vitamin D | One of the most common and modifiable contributors to elevated inflammatory markers |
This is the difference between confirming that everything looks “normal” on a standard panel and actually understanding what your body’s internal environment is doing.
The Bottom LineThe absence of obvious symptoms is not the same as the absence of a problem. Chronic low-grade inflammation doesn’t produce the signals that send people to urgent care or prompt their physician to investigate further. It just quietly shifts the metabolic environment in a direction that makes everything else harder.
If you’ve been doing the right things (eating well, moving consistently, sleeping adequately, investing in your health) and the results still aren’t matching the effort, chronic inflammation may be the variable no one has looked for yet.
It’s measurable. It’s modifiable. And identifying it early gives you the opportunity to address it before it compounds.
If you’re ready to find out, a discovery call is the place to start. We’ll review your history, your goals, and whether a comprehensive functional medicine workup makes sense for where you are.
Book a Discovery Call →It’s a persistent, low-level activation of the immune system that never fully resolves. Inflammatory cytokines such as IL-6, TNF-alpha, and IL-1 beta stay elevated in the background, driven by inputs like visceral fat, chronic stress, poor sleep, gut dysbiosis, nutrient deficiencies, and metabolic dysfunction.
It usually shows up as a pattern rather than one symptom: weight that resists change, hormone therapy that underperforms, fatigue that sleep doesn’t fix, and joint stiffness without a clear diagnosis.
Below 1.0 mg/L is generally considered lower risk and is the functional medicine target. Levels between 1.0 and 3.0 mg/L are often not flagged on standard reports but can still reflect meaningful inflammatory load, and levels above 3.0 mg/L are associated with higher cardiovascular risk.
They have a bidirectional relationship: each promotes and sustains the other. Elevated fasting insulin signals that the metabolic conditions driving inflammation are active, often years before glucose or A1c change.
A thorough workup can include hs-CRP, fasting insulin, HOMA-IR, an advanced lipid panel, homocysteine, a comprehensive thyroid panel with antibodies, sex hormones and cortisol, and vitamin D.
For educational purposes only. Not a diagnosis, and not a substitute for care from your healthcare provider. Talk with your provider about which labs are right for you.
